Lawrence Steinman

Lawrence Steinman is a declared insider at 4 companies (board member); the most frequent names are Pasithea Therapeutics Corp., BioAtla, Inc. and FORUM MARKETS Inc. In total, 28 filings cover trades dated from 24 June 2019 to 28 November 2025.

Both buying and selling appear: 5 purchases worth €175k, against 4 sales worth €56k. Taken together, the purchases exceed the sales by €119k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 17 share grants. Since January 2025: 1 purchase and no sales on the market.

Half of the purchases are above €21k and half below. 4 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 1 December 2025 came the latest disclosure, an open-market purchase for €86k in Pasithea Therapeutics Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.